Technology in Parkinson's disease

Challenges and opportunities

on behalf of the Movement Disorders Society Task Force on Technology

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the “big data” acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD.

Original languageEnglish
Pages (from-to)1272-1282
Number of pages11
JournalMovement Disorders
Volume31
Issue number9
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Parkinson Disease
Technology
Advisory Committees
Miniaturization
Therapeutics
Movement Disorders
Patient Compliance
Early Diagnosis
Biomarkers
Quality of Life
Research Personnel
Research

Keywords

  • digital biomarkers
  • digital health
  • eHealth
  • Parkinson's disease
  • precision medicine
  • remote monitoring
  • technology
  • wearable technology

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

on behalf of the Movement Disorders Society Task Force on Technology (2016). Technology in Parkinson's disease: Challenges and opportunities. Movement Disorders, 31(9), 1272-1282. https://doi.org/10.1002/mds.26642

Technology in Parkinson's disease : Challenges and opportunities. / on behalf of the Movement Disorders Society Task Force on Technology.

In: Movement Disorders, Vol. 31, No. 9, 01.09.2016, p. 1272-1282.

Research output: Contribution to journalArticle

on behalf of the Movement Disorders Society Task Force on Technology 2016, 'Technology in Parkinson's disease: Challenges and opportunities', Movement Disorders, vol. 31, no. 9, pp. 1272-1282. https://doi.org/10.1002/mds.26642
on behalf of the Movement Disorders Society Task Force on Technology. Technology in Parkinson's disease: Challenges and opportunities. Movement Disorders. 2016 Sep 1;31(9):1272-1282. https://doi.org/10.1002/mds.26642
on behalf of the Movement Disorders Society Task Force on Technology. / Technology in Parkinson's disease : Challenges and opportunities. In: Movement Disorders. 2016 ; Vol. 31, No. 9. pp. 1272-1282.
@article{ce87430ff4304c93adb31a80c138bca8,
title = "Technology in Parkinson's disease: Challenges and opportunities",
abstract = "The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the “big data” acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD.",
keywords = "digital biomarkers, digital health, eHealth, Parkinson's disease, precision medicine, remote monitoring, technology, wearable technology",
author = "{on behalf of the Movement Disorders Society Task Force on Technology} and Espay, {Alberto J.} and Paolo Bonato and Nahab, {Fatta B.} and Walter Maetzler and Dean, {John M.} and Jochen Klucken and Eskofier, {Bjoern M.} and Aristide Merola and Fay Horak and Lang, {Anthony E.} and Ralf Reilmann and Joe Giuffrida and Alice Nieuwboer and Malcolm Horne and Little, {Max A.} and Irene Litvan and Tanya Simuni and Dorsey, {E. Ray} and Burack, {Michelle A.} and Ken Kubota and A. Kamondi and Catarina Godinho and Daneault, {Jean Francois} and Georgia Mitsi and Lothar Krinke and Hausdorff, {Jeffery M.} and Bloem, {Bastiaan R.} and Spyros Papapetropoulos",
year = "2016",
month = "9",
day = "1",
doi = "10.1002/mds.26642",
language = "English",
volume = "31",
pages = "1272--1282",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Technology in Parkinson's disease

T2 - Challenges and opportunities

AU - on behalf of the Movement Disorders Society Task Force on Technology

AU - Espay, Alberto J.

AU - Bonato, Paolo

AU - Nahab, Fatta B.

AU - Maetzler, Walter

AU - Dean, John M.

AU - Klucken, Jochen

AU - Eskofier, Bjoern M.

AU - Merola, Aristide

AU - Horak, Fay

AU - Lang, Anthony E.

AU - Reilmann, Ralf

AU - Giuffrida, Joe

AU - Nieuwboer, Alice

AU - Horne, Malcolm

AU - Little, Max A.

AU - Litvan, Irene

AU - Simuni, Tanya

AU - Dorsey, E. Ray

AU - Burack, Michelle A.

AU - Kubota, Ken

AU - Kamondi, A.

AU - Godinho, Catarina

AU - Daneault, Jean Francois

AU - Mitsi, Georgia

AU - Krinke, Lothar

AU - Hausdorff, Jeffery M.

AU - Bloem, Bastiaan R.

AU - Papapetropoulos, Spyros

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the “big data” acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD.

AB - The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the “big data” acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD.

KW - digital biomarkers

KW - digital health

KW - eHealth

KW - Parkinson's disease

KW - precision medicine

KW - remote monitoring

KW - technology

KW - wearable technology

UR - http://www.scopus.com/inward/record.url?scp=84985911015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985911015&partnerID=8YFLogxK

U2 - 10.1002/mds.26642

DO - 10.1002/mds.26642

M3 - Article

VL - 31

SP - 1272

EP - 1282

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 9

ER -